Literature DB >> 1485606

A rapid method to isolate platelets from human blood by density gradient centrifugation.

M Hoffman1, D M Monroe, H R Roberts.   

Abstract

Platelets can be damaged easily or activated during isolation, making them unsuitable for functional studies. The most common technique for isolating platelets involves centrifugation. Although gentler methods have been devised to isolate platelets by density gradient centrifugation or electrophoresis, these techniques either result in a relatively dilute platelet preparation or are time-consuming. A simple, gentle technique for isolating concentrated platelet preparations for experimental or clinical use is reported. Freshly drawn whole blood was spun over a commercially available density gradient medium for 30 minutes. The mononuclear cell layer (which also contains most of the platelets) was collected and nucleated cells were pelleted by centrifugation. The recovery of platelets was about 60%. Contamination with leukocytes was less than 1%, and the platelet concentration was about 130% of blood concentration. Higher concentrations can be obtained if more whole blood is layered onto the Mono-Poly Resolving Medium (MPRM; Flow Laboratories, McLean, VA). About 10% of the platelets expressed the activation marker GMP-140 by flow cytometric analysis. They could be activated by thrombin so that 70% to 90% of the platelets expressed GMP-140. Thus, this technique can rapidly and easily yield a functionally intact platelet preparation. This preparation can be purified again if needed. No specialized skills or equipment are needed. A significant advantage of the method is that platelets can be obtained from thrombocytopenic patients in final concentrations that are high enough to use for platelet function testing.

Entities:  

Mesh:

Year:  1992        PMID: 1485606     DOI: 10.1093/ajcp/98.5.531

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  12 in total

1.  The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.

Authors:  María Virginia Tribulatti; Juan Mucci; Nico Van Rooijen; María Susana Leguizamón; Oscar Campetella
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.

Authors:  K M Bompiani; D M Monroe; F C Church; B A Sullenger
Journal:  J Thromb Haemost       Date:  2012-05       Impact factor: 5.824

3.  Human platelets express endothelial protein C receptor, which can be utilized to enhance localization of factor VIIa activity.

Authors:  A M Fager; K R Machlus; M Ezban; M Hoffman
Journal:  J Thromb Haemost       Date:  2018-06-27       Impact factor: 5.824

4.  Photonic technologies for liquid biopsies: recent advances and open research challenges.

Authors:  Francesco Dell'Olio; Judith Su; Thomas Huser; Virginie Sottile; Luis Enrique Cortés-Hernández; Catherine Alix-Panabières
Journal:  Laser Photon Rev       Date:  2020-12-02       Impact factor: 13.138

Review 5.  Platelets and their biomimetics for regenerative medicine and cancer therapies.

Authors:  Zhenhua Li; Shiqi Hu; Ke Cheng
Journal:  J Mater Chem B       Date:  2018-10-22       Impact factor: 6.331

6.  Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin.

Authors:  Shahid M Nimjee; Sabah Oney; Zoya Volovyk; Kristin M Bompiani; Steve B Long; Maureane Hoffman; Bruce A Sullenger
Journal:  RNA       Date:  2009-10-21       Impact factor: 4.942

7.  HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages.

Authors:  James Dressman; Jeanie Kincer; Sergey V Matveev; Ling Guo; Richard N Greenberg; Theresa Guerin; David Meade; Xiang-An Li; Weifei Zhu; Annette Uittenbogaard; Melinda E Wilson; Eric J Smart
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

8.  Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability.

Authors:  Robert A Campbell; Katherine A Overmyer; Craig H Selzman; Brett C Sheridan; Alisa S Wolberg
Journal:  Blood       Date:  2009-10-01       Impact factor: 22.113

9.  Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.

Authors:  Matthew Duvernay; Summer Young; David Gailani; Jonathan Schoenecker; Heidi E Hamm; Heidi Hamm
Journal:  Mol Pharmacol       Date:  2013-01-10       Impact factor: 4.436

10.  A rationally designed heparin, M118, has anticoagulant activity similar to unfractionated heparin and different from Lovenox in a cell-based model of thrombin generation.

Authors:  Zoya Volovyk; Dougald M Monroe; YiWei Qi; Richard Becker; Maureane Hoffman
Journal:  J Thromb Thrombolysis       Date:  2009-08       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.